Mutation
Chemical Compounds
100%
Carnitine
Chemical Compounds
96%
Tandem Mass Spectrometry
Medicine & Life Sciences
88%
Neonatal Sepsis
Medicine & Life Sciences
80%
acylcarnitine
Medicine & Life Sciences
73%
Ornithine Carbamoyltransferase Deficiency Disease
Medicine & Life Sciences
66%
Liver Transplantation
Medicine & Life Sciences
65%
Serum
Medicine & Life Sciences
64%
Yokoi, K. ,
Nakajima, Y. ,
Takahashi, Y. ,
Hamajima, T. ,
Tajima, G. ,
Saito, K. ,
Miyai, S. ,
Inagaki, H. ,
Yoshikawa, T. ,
Kurahashi, H. &
Ito, T. ,
01-2023 ,
In: JIMD Reports. 64 ,
1 ,
p. 3-9 7 p. 研究成果: Article › 査読
Rhabdomyolysis
100%
VLCAD deficiency
92%
Acyl-CoA
77%
acylcarnitine
75%
Organizations
67%
Matsumoto, Y. ,
Ikezumi, Y. ,
Kondoh, T. ,
Yokoi, K. ,
Nakajima, Y. ,
Kumagai, N. ,
Kato, T. ,
Kurahashi, H. &
Ito, T. ,
2022 ,
In: Tohoku Journal of Experimental Medicine. 258 ,
3 ,
p. 183-193 11 p. 研究成果: Article › 査読
Complement Factor I
100%
Thrombotic
89%
Thrombotic Microangiopathies
79%
Streptococcus pneumoniae
59%
Thrombocytopenia
54%
Kondoh, T. ,
Nakajima, Y. ,
Yokoi, K. ,
Matsumoto, Y. ,
Inagaki, H. ,
Kato, T. ,
Nakajima, Y. ,
Ito, T. ,
Yoshikawa, T. &
Kurahashi, H. ,
2022 ,
In: Tohoku Journal of Experimental Medicine. 256 ,
1 ,
p. 37-41 5 p. 研究成果: Article › 査読
Mason-Type Diabetes
100%
Lipase
72%
Insulin Derivative
67%
Esters
66%
Mutation
55%
Yokoi, K. ,
Nakajima, Y. ,
Sudo, Y. ,
Mariya, T. ,
Kawamura, R. ,
Tsutsumi, M. ,
Inagaki, H. ,
Yoshikawa, T. ,
Ito, T. &
Kurahashi, H. ,
11-2022 ,
In: JIMD Reports. 63 ,
6 ,
p. 575-580 6 p. 研究成果: Article › 査読
Maple Syrup Urine Disease
100%
Branched-Chain Amino Acid
91%
Chain Reaction
62%
Disorder
54%
Mutation
54%
Wakamatsu, M. ,
Kojima, D. ,
Muramatsu, H. ,
Okuno, Y. ,
Kataoka, S. ,
Nakamura, F. ,
Sakai, Y. ,
Tsuge, I. ,
Ito, T. ,
Ueda, K. ,
Saito, A. ,
Morihana, E. ,
Ito, Y. ,
Ohashi, N. ,
Tanaka, M. ,
Tanaka, T. ,
Kojima, S. ,
Nakajima, Y. ,
Ito, T. &
Takahashi, Y. ,
11-2022 ,
In: Journal of Clinical Immunology. 42 ,
8 ,
p. 1696-1707 12 p. 研究成果: Article › 査読
Severe Combined Immunodeficiency
100%
Neonatal Screening
91%
T-Cell Antigen Receptor
79%
Genetic Recombination
75%
High-Throughput Nucleotide Sequencing
74%